Apricot Capital (Shanghai) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
57
- Portfolio
-
40
- Exits
-
6
Apricot Capital (Shanghai) General Information
Description
Founded in 2015, Apricot Capital (Shanghai) is a venture capital firm headquartered in Shanghai, China. It seeks to make investments in biopharmaceuticals, medical devices, and medical diagnostics and services sectors.
Contact Information
Website
www.apricot-capital.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- No. 1479 Fuxing Middle Road
- Xuhui District
- Shanghai
- China
+86 021 0000 0000
Apricot Capital (Shanghai) Investments (57)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Arnatar Therapeutics | 19-Sep-2022 | Seed Round | 000.00 | Drug Discovery | Startup | |
| 00000000 | 05-Sep-2022 | 00000 00000 | 00.000 | Specialty Chemicals | Generating Revenue | |
| 000000 0000000000 | 01-Aug-2022 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | 0000000 0000 |
| 0000000000 | 04-Jul-2022 | 00000 00000 | 00000 | Practice Management (Healthcare) | Generating Revenue | |
| 0000000 0000000 | 21-Jun-2022 | 00000 00000 | 000.00 | Surgical Devices | Clinical Trials - General | 0000 00000 |
| 000000 00000000000 | 20-Jun-2022 | 00000 00000 | 000.00 | Biotechnology | Startup | |
| 0000000 0000000000 | 13-Jun-2022 | 00000 00000 | 000.00 | Biotechnology | Startup | |
| 00 000000000 | 21-Mar-2022 | 0000 00000 | 000.00 | Biotechnology | Startup | 0000 00000 |
| SniperDX | 26-Sep-2021 | Later Stage VC | 000.00 | Diagnostic Equipment | Generating Revenue | |
| Eternbio | 01-Sep-2021 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | 0000000 0000 |
Apricot Capital (Shanghai) Exits (6)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| MicroPort Electrophysiology | 30-Aug-2022 | IPO | 00000 |
| 0000000 0000000000 | 02-Aug-2021 | 000 | 00000 |
| 00000 000000000 | 24-Apr-2020 | 000 | 00000 |
| TopAlliance | 24-Dec-2018 | IPO | |
| MicroPort CardioFlow | 23-Mar-2018 | Secondary Transaction - Private |
Apricot Capital (Shanghai) Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Apricot Capital (Shanghai) Team (6)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Haigang Chen | Managing Partner | 0 | 0 | Shanghai, China | |
| Wenyi Liu Ph.D | Managing Partner | Shanghai, China | |||
| Weixiong Mao | Founding Partner | Shanghai, China | |||
| Xu Tao | Partner | Shanghai, China | |||
| Yi Liu | Partner | Shanghai, China |
Apricot Capital (Shanghai) Co-Investors (75)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Hillhouse Capital Group | 3 | 0 |
|
|
|
| Huagai Capital | 0 | 0 |
|
|
|
| Legend Capital | 0 | 0 |
|
|
|
| Loyal Valley Capital | 0 | 0 | 0 |
|
|
| IDG Capital | 0 |
|
|